Top down VP's dropping like flies due to large salaries. Top management leaders don't need to be duplicated if a big pharma company buys Eisai. RSD's & Managers next...stay tuned.
All Eisai has to offer is R&D facilities, dwindling products, and a new home office building.
My guess....Pfizer
All Eisai has to offer is R&D facilities, dwindling products, and a new home office building.
My guess....Pfizer